DK3464305T3 - Fremgangsmåder til fremstilling af oligomerer - Google Patents
Fremgangsmåder til fremstilling af oligomerer Download PDFInfo
- Publication number
- DK3464305T3 DK3464305T3 DK17731336.8T DK17731336T DK3464305T3 DK 3464305 T3 DK3464305 T3 DK 3464305T3 DK 17731336 T DK17731336 T DK 17731336T DK 3464305 T3 DK3464305 T3 DK 3464305T3
- Authority
- DK
- Denmark
- Prior art keywords
- oligomers
- processes
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662341049P | 2016-05-24 | 2016-05-24 | |
| US201662357166P | 2016-06-30 | 2016-06-30 | |
| US201662357072P | 2016-06-30 | 2016-06-30 | |
| US201662356923P | 2016-06-30 | 2016-06-30 | |
| US201662357153P | 2016-06-30 | 2016-06-30 | |
| US201762508256P | 2017-05-18 | 2017-05-18 | |
| PCT/US2017/034235 WO2017205496A1 (en) | 2016-05-24 | 2017-05-24 | Processes for preparing oligomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3464305T3 true DK3464305T3 (da) | 2024-10-28 |
Family
ID=59078165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17731336.8T DK3464305T3 (da) | 2016-05-24 | 2017-05-24 | Fremgangsmåder til fremstilling af oligomerer |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10875880B2 (da) |
| EP (2) | EP3464305B1 (da) |
| JP (2) | JP7008642B2 (da) |
| KR (1) | KR102506298B1 (da) |
| CN (1) | CN109563114B (da) |
| AU (1) | AU2017269355B2 (da) |
| BR (2) | BR112018074346B1 (da) |
| CA (1) | CA3025339A1 (da) |
| CO (1) | CO2018013838A2 (da) |
| DK (1) | DK3464305T3 (da) |
| ES (1) | ES2993738T3 (da) |
| FI (1) | FI3464305T3 (da) |
| HR (1) | HRP20241428T1 (da) |
| IL (1) | IL263149B2 (da) |
| MA (2) | MA49775A (da) |
| MD (1) | MD3464305T2 (da) |
| MX (2) | MX2018014472A (da) |
| SA (1) | SA518400500B1 (da) |
| SG (1) | SG10202101830WA (da) |
| TW (2) | TWI738784B (da) |
| WO (1) | WO2017205496A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
| JP6987081B2 (ja) | 2016-05-24 | 2021-12-22 | サレプタ セラピューティクス， インコーポレイテッド | ホスホロジアミダートモルホリノオリゴマーを調製するためのプロセス |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| MA45362A (fr) | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | Procédés de préparation d'oligomères morpholino de phosphorodiamidate |
| US10875880B2 (en) | 2016-05-24 | 2020-12-29 | Sarepta Therapeutics, Inc. | Processes for preparing oligomers |
| CN109152775B (zh) * | 2016-06-30 | 2022-04-26 | 萨勒普塔医疗公司 | 制备磷酸二酰胺吗啉代寡聚物的方法 |
| MX2018014160A (es) * | 2016-06-30 | 2019-04-01 | Sarepta Therapeutics Inc | Procesos para preparar oligomeros de morfolino fosforodiamidato. |
| TWI812647B (zh) * | 2017-09-25 | 2023-08-21 | 美商薩羅塔治療公司 | 經由速流合成以製備磷醯二胺嗎啉代寡聚物之製程 |
| WO2019209764A2 (en) * | 2018-04-26 | 2019-10-31 | Sarepta Therapeutics, Inc. | Exon skipping oligomers and oligomer conjugates for muscular dystrophy |
| WO2024163762A2 (en) * | 2023-02-01 | 2024-08-08 | Alnylam Pharmaceuticals, Inc. | Six membered ring containing oligomers |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0216860B1 (en) | 1985-03-15 | 1992-10-28 | SUMMERTON, James | Stereoregular polynucleotide-binding polymers |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| EP0433345B1 (en) | 1988-09-01 | 1994-04-20 | Forskningscenter Riso | Peptide synthesis method and solid support for use in the method |
| JP3572617B2 (ja) | 1993-12-29 | 2004-10-06 | 藤沢薬品工業株式会社 | ピラゾロピリジンアデノシン拮抗剤 |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| US7572582B2 (en) | 1997-09-12 | 2009-08-11 | Exiqon A/S | Oligonucleotide analogues |
| US7084125B2 (en) | 1999-03-18 | 2006-08-01 | Exiqon A/S | Xylo-LNA analogues |
| KR100782896B1 (ko) | 1999-05-04 | 2007-12-06 | 엑시콘 에이/에스 | Ｌ-리보-ｌｎａ 유사체 |
| JP2003533986A (ja) | 2000-05-04 | 2003-11-18 | エイブイアイ バイオファーマ， インコーポレイテッド | スプライス領域アンチセンス組成物および方法 |
| WO2003020739A2 (en) | 2001-09-04 | 2003-03-13 | Exiqon A/S | Novel lna compositions and uses thereof |
| US7569575B2 (en) | 2002-05-08 | 2009-08-04 | Santaris Pharma A/S | Synthesis of locked nucleic acid derivatives |
| WO2004043978A2 (en) | 2002-11-05 | 2004-05-27 | Isis Pharmaceuticals, Inc. | 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| US7759513B2 (en) | 2003-02-21 | 2010-07-20 | Nigu Chemie Gmbh | Photolabile protective groups for improved processes to prepare oligonucleotide arrays |
| EP3808845A1 (en) | 2004-06-28 | 2021-04-21 | The University Of Western Australia | Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| JP2010505741A (ja) * | 2006-05-10 | 2010-02-25 | エイブイアイ バイオファーマ， インコーポレイテッド | カチオン性のサブユニット間結合を有するオリゴヌクレオチドアナログ |
| US9371348B2 (en) | 2006-11-27 | 2016-06-21 | The Trustees Of The University Of Pennsylvania | Photocleavable oligonucleotide and uses thereof |
| BR122019021332A8 (pt) * | 2007-11-15 | 2022-12-06 | Avi Biopharma Inc | Processo de síntese de oligômeros de morfolino |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| CN102203253B (zh) | 2008-10-24 | 2016-04-06 | 萨雷普塔治疗公司 | 用于dmd的多外显子跳跃组合物 |
| DK2417257T3 (da) | 2009-04-10 | 2016-06-06 | Ass Inst De Myologie | Tricyclo-dna-antisense-oligonukleotider, sammensætninger, og fremgangsmåder til behandlingen af sygdom |
| CA2780563A1 (en) | 2009-11-12 | 2011-05-19 | The University Of Western Australia | Antisense molecules and methods for treating pathologies |
| KR20200133284A (ko) * | 2010-05-28 | 2020-11-26 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체 |
| TWI463423B (zh) * | 2010-05-28 | 2014-12-01 | Poynt Corp | 用以針對基於三維形狀之廣告系統使用位置資訊的方法 |
| TWI541024B (zh) * | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
| SI2623507T1 (sl) | 2010-09-30 | 2017-04-26 | Nippon Shinyaku Co.,Ltd. | Derivati morfolino-nukleinske kisline |
| MX2013009191A (es) * | 2011-02-08 | 2013-11-04 | Charlotte Mecklenburg Hospital | Oligonucleotidos antisentido. |
| WO2013026142A1 (en) | 2011-08-23 | 2013-02-28 | The Royal Institution For The Advancement Of Learning/Mcgill University | Ionic tags for synthesis of oligoribonucleotides |
| PL2581448T3 (pl) | 2011-10-13 | 2015-08-31 | Association Inst De Myologie | Tricyklo-tiofosforanowy DNA |
| BR112014011875B1 (pt) | 2011-11-18 | 2022-01-04 | Sarepta Therapeutics, Inc | Oligonucleotídeos funcionalmente modificados e subunidades dos mesmos |
| US9944926B2 (en) * | 2011-11-30 | 2018-04-17 | Sarepta Therapeutics, Inc. | Induced exon inclusion in spinal muscle atrophy |
| JP6141770B2 (ja) * | 2011-12-28 | 2017-06-07 | 日本新薬株式会社 | アンチセンス核酸 |
| EP3287531B1 (en) | 2012-02-28 | 2019-06-19 | Agilent Technologies, Inc. | Method for attaching a counter sequence to a nucleic acid sample |
| CN102702265A (zh) * | 2012-05-14 | 2012-10-03 | 天津特安化学科技有限公司 | 一种固相合成磷酰二胺吗啉代寡核苷酸及方法 |
| US20160040162A1 (en) * | 2013-03-14 | 2016-02-11 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| KR102258326B1 (ko) * | 2013-03-14 | 2021-06-02 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이영양증의 치료를 위한 엑손 스키핑 조성물 |
| EA201591792A1 (ru) | 2013-03-15 | 2016-02-29 | Сарепта Терапьютикс, Инк. | Улучшенные композиции для лечения мышечной дистрофии |
| DK3015467T3 (da) | 2013-05-24 | 2025-02-10 | Ajinomoto Kk | Morpholino-oligonukleotidfremstillingsfremgangsmåde |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| MA45362A (fr) | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | Procédés de préparation d'oligomères morpholino de phosphorodiamidate |
| JP6987081B2 (ja) | 2016-05-24 | 2021-12-22 | サレプタ セラピューティクス， インコーポレイテッド | ホスホロジアミダートモルホリノオリゴマーを調製するためのプロセス |
| US10875880B2 (en) | 2016-05-24 | 2020-12-29 | Sarepta Therapeutics, Inc. | Processes for preparing oligomers |
| CA3024456A1 (en) | 2016-05-24 | 2017-11-30 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| MX2019006882A (es) | 2016-12-19 | 2019-08-16 | Sarepta Therapeutics Inc | Conjugados de oligomeros de omision de exon para distrofia muscular. |
| RS65583B1 (sr) | 2016-12-19 | 2024-06-28 | Sarepta Therapeutics Inc | Oligomerni konjugati za preskakanje egzona za mišićnu distrofiju |
| MD3554552T2 (ro) | 2016-12-19 | 2022-12-31 | Sarepta Therapeutics Inc | Conjugați oligomeri de omitere a exonilor pentru distrofie musculară |
| EA201991450A1 (ru) | 2017-09-22 | 2019-12-30 | Сарепта Терапьютикс, Инк. | Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии |
-
2017
- 2017-05-24 US US16/303,356 patent/US10875880B2/en active Active
- 2017-05-24 SG SG10202101830WA patent/SG10202101830WA/en unknown
- 2017-05-24 BR BR112018074346-1A patent/BR112018074346B1/pt active IP Right Grant
- 2017-05-24 MX MX2018014472A patent/MX2018014472A/es unknown
- 2017-05-24 MX MX2021008539A patent/MX2021008539A/es unknown
- 2017-05-24 EP EP17731336.8A patent/EP3464305B1/en active Active
- 2017-05-24 CN CN201780037531.XA patent/CN109563114B/zh active Active
- 2017-05-24 DK DK17731336.8T patent/DK3464305T3/da active
- 2017-05-24 WO PCT/US2017/034235 patent/WO2017205496A1/en active Application Filing
- 2017-05-24 AU AU2017269355A patent/AU2017269355B2/en active Active
- 2017-05-24 BR BR122022014984-7A patent/BR122022014984B1/pt active IP Right Grant
- 2017-05-24 EP EP19174995.1A patent/EP3564248A1/en active Pending
- 2017-05-24 MA MA049775A patent/MA49775A/fr unknown
- 2017-05-24 ES ES17731336T patent/ES2993738T3/es active Active
- 2017-05-24 MD MDE20190423T patent/MD3464305T2/ro unknown
- 2017-05-24 FI FIEP17731336.8T patent/FI3464305T3/fi active
- 2017-05-24 HR HRP20241428TT patent/HRP20241428T1/hr unknown
- 2017-05-24 CA CA3025339A patent/CA3025339A1/en active Pending
- 2017-05-24 KR KR1020187036117A patent/KR102506298B1/ko active Active
- 2017-05-24 TW TW106117189A patent/TWI738784B/zh active
- 2017-05-24 TW TW110113938A patent/TWI801843B/zh active
- 2017-05-24 JP JP2018562078A patent/JP7008642B2/ja active Active
- 2017-05-24 MA MA45154A patent/MA45154B1/fr unknown
-
2018
- 2018-11-20 IL IL263149A patent/IL263149B2/en unknown
- 2018-11-24 SA SA518400500A patent/SA518400500B1/ar unknown
- 2018-12-19 CO CONC2018/0013838A patent/CO2018013838A2/es unknown
-
2020
- 2020-11-16 US US17/098,935 patent/US11384105B2/en active Active
-
2021
- 2021-07-15 JP JP2021117392A patent/JP2021176967A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
| DK3464305T3 (da) | Fremgangsmåder til fremstilling af oligomerer | |
| DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
| IL264143B (en) | Processes for preparing olaparib | |
| DK3464306T3 (da) | Fremgangsmåder til fremstilling af phosphorodiamidat-morpholino-oligomerer | |
| DK3377201T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3294865T3 (da) | Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider | |
| DK3166904T3 (da) | Fremgangsmåde til fremstilling af betonelementer | |
| DK3312270T3 (da) | Fremgangsmåde til fremstilling af plader med høj ydeevne | |
| DK3416936T3 (da) | Fremgangsmåde til fremstilling af methanol | |
| DK3359522T3 (da) | Proces til fremstilling af N-Boc-bifenylalaninol | |
| DK3218396T3 (da) | Fremgangsmåde til fremstilling af højaffinitets antistoffer | |
| DK3481811T3 (da) | Industriel fremgangsmåde til forberedelse af cariprazin | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3262023T3 (da) | Fremgangsmåde til fremstillingen af diener | |
| DK3490938T3 (da) | Fremgangsmåder til dannelse af titancatecholkomplekser | |
| DK3443110T3 (da) | Fermenteringsproces til fremstilling af maltosyl-isomalto-oligosaccharider (mimo) | |
| DK3166923T3 (da) | Fremgangsmåde til fremstilling af substituerede phenylalkaner | |
| DK3495339T3 (da) | Fremgangsmåde til fremstilling af reaktionsprodukt | |
| IL263052B (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| DK3286209T3 (da) | Fremgangsmåde til fremstilling af gonadotrophin | |
| DK3259364T3 (da) | Fremgangsmåder til styring af proteasefremstilling | |
| DK3256460T3 (da) | Fremgangsmåde til fremstilling af lactid | |
| DK3224225T3 (da) | Fremgangsmåde til fremstilling af ethen | |
| DK3592723T3 (da) | Fremgangsmåde til fremstilling af 3,3,3-trifluorprop-1-en |